6533b825fe1ef96bd1282089

RESEARCH PRODUCT

Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma.

Giuseppe BadalamentiGiuseppe PerroneAngelo Paolo Dei TosAlfonso BaldiPaolo G. CasaliRoberta SanfilippoDaniele SantiniGiuseppe ToniniAndrea Onetti-mudaSilvia StacchiottiMichele IulianiPaola ColliniFrancesco PantanoBruno VincenziAlessandro Gronchi

subject

LeiomyosarcomaDrugCancer Researchbiologybusiness.industrymedia_common.quotation_subjectTransporterEquilibrative nucleoside transporter 1medicine.diseaseGemcitabineOncologybiology.proteinCancer researchMedicineAngiosarcomaSarcomabusinessmedicine.drugmedia_common

description

11062Background: Human equilibrative nucleoside transporter 1 (hENT1) is the major gemcitabine transporter into cells. Gemcitabine is an active drug in different sarcoma subtypes including leiomyos...

https://doi.org/10.1200/jco.2016.34.15_suppl.11062